Centessa Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2020
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '20 Dec 31, 2020
Cash & Equivalents	62.43	61.3	383.22	128.03	393.64	5
Short-Term Investments	214.16	233.28	98.96	128.52	-	-
Cash & Short-Term Investments	276.59	294.58	482.18	256.55	393.64	5
Cash Growth	-2.78%	-38.91%	87.95%	-34.83%	7768.16%	-
Other Receivables	56.43	53.92	43.77	37.82	24.17	-
Total Trade Receivables	56.43	53.92	43.77	37.82	24.17	-
Other Current Assets	15.66	19.38	10.46	20.73	19.94	0.01
Total Current Assets	348.68	367.88	536.41	315.09	437.75	5.01
Net Property, Plant & Equipment	10.52	10.85	11.76	12.95	1.17	-
Long-Term Investments	257.12	282.55	-	-	-	-
Other Long-Term Assets	25.45	26.22	28.63	32.2	5.39	0.25
Total Assets	641.76	687.5	576.8	360.25	444.31	5.26
Accounts Payable	10.66	7.58	7.14	11.82	13.84	0.02
Accrued Expenses	25.92	35.35	50.86	27.57	24.5	3.46
Short-Term Debt	-	-	-	-	-	4.17
Other Current Liabilities	-	-	-	-	-	0.83
Total Current Liabilities	36.57	42.94	58	39.39	38.34	8.48
Long-Term Debt	110.44	110.1	108.94	75.7	69.8	-
Long-Term Leases	7.37	7.57	8.29	8.89	-	-
Other Long-Term Liabilities	0.03	0.03	0.03	0.03	-	-
Total Long-Term Liabilities	117.84	117.7	117.26	84.62	69.8	-
Total Liabilities	154.42	160.63	175.25	124	108.14	8.48
Common Stock	0.42	0.41	0.36	0.27	0.27	0.02
Additional Paid-in Capital	1,751	1,710	1,386	987.42	939.26	-
Accumulated Other Comprehensive Income	1.41	2.71	4.21	1.49	-1.5	-0.09
Retained Earnings	-1,265	-1,186	-988.7	-752.95	-601.86	-3.15
Shareholders' Equity	487.35	526.86	401.55	236.24	336.17	-3.21
Total Liabilities & Equity	641.76	687.5	576.8	360.25	444.31	5.26
Total Debt	117.81	117.67	117.23	84.59	69.8	4.17
Net Cash (Debt)	158.78	176.91	364.95	171.96	323.84	0.83
Net Cash Growth	-10.25%	-51.52%	112.23%	-46.90%	38823.56%	-
Net Cash Per Share	1.13	1.30	3.19	1.79	3.47	0.21
Book Value	487.35	526.86	401.55	236.24	336.17	-3.21
Book Value Per Share	3.46	3.88	3.51	2.46	3.60	-0.82
Tangible Book Value	487.35	526.86	401.55	236.24	336.17	-3.21
Tangible Book Value Per Share	3.46	3.88	3.51	2.46	3.60	-0.82

Updated Mar 31, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.